Osteonic Co. Ltd (226400) - Total Assets
Based on the latest financial reports, Osteonic Co. Ltd (226400) holds total assets worth ₩96.14 Billion KRW (≈ $65.15 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of Osteonic Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
Osteonic Co. Ltd - Total Assets Trend (2015–2024)
This chart illustrates how Osteonic Co. Ltd's total assets have evolved over time, based on quarterly financial data. Explore how much of Osteonic Co. Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Osteonic Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Osteonic Co. Ltd's total assets of ₩96.14 Billion consist of 59.5% current assets and 40.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩9.98 Billion | 11.1% |
| Accounts Receivable | ₩14.62 Billion | 16.3% |
| Inventory | ₩16.73 Billion | 18.6% |
| Property, Plant & Equipment | ₩24.49 Billion | 27.2% |
| Intangible Assets | ₩5.09 Billion | 5.7% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Osteonic Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Osteonic Co. Ltd (226400) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Osteonic Co. Ltd's current assets represent 59.5% of total assets in 2024, a decrease from 72.6% in 2015.
- Cash Position: Cash and equivalents constituted 11.1% of total assets in 2024, down from 15.3% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 2015.
- Asset Diversification: The largest asset category is property, plant & equipment at 27.2% of total assets.
Osteonic Co. Ltd Competitors by Total Assets
Key competitors of Osteonic Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
Osteonic Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.98 | 2.86 | 2.08 |
| Quick Ratio | 1.91 | 1.91 | 1.71 |
| Cash Ratio | 0.00 | 0.57 | 0.00 |
| Working Capital | ₩37.44 Billion | ₩32.55 Billion | ₩21.91 Billion |
Osteonic Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Osteonic Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.08 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 25.3% |
| Total Assets | ₩89.92 Billion |
| Market Capitalization | $59.61 Million USD |
Valuation Analysis
Below Book Valuation: The market values Osteonic Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Osteonic Co. Ltd's assets grew by 25.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Osteonic Co. Ltd (2015–2024)
The table below shows the annual total assets of Osteonic Co. Ltd from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩89.92 Billion ≈ $60.94 Million |
+25.34% |
| 2023-12-31 | ₩71.74 Billion ≈ $48.62 Million |
+16.60% |
| 2022-12-31 | ₩61.53 Billion ≈ $41.69 Million |
-4.12% |
| 2021-12-31 | ₩64.17 Billion ≈ $43.49 Million |
+1.33% |
| 2020-12-31 | ₩63.33 Billion ≈ $42.92 Million |
+21.05% |
| 2019-12-31 | ₩52.32 Billion ≈ $35.45 Million |
+18.91% |
| 2018-12-31 | ₩44.00 Billion ≈ $29.82 Million |
+48.36% |
| 2017-12-31 | ₩29.66 Billion ≈ $20.10 Million |
+37.49% |
| 2016-12-31 | ₩21.57 Billion ≈ $14.62 Million |
+96.91% |
| 2015-12-31 | ₩10.95 Billion ≈ $7.42 Million |
-- |
About Osteonic Co. Ltd
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. It offers CMF systems, including neuro plating systems, maxillofacial plating systems, mandible plating systems, IMF screws, power screw drivers, 90 angled screw driver, customized neuro 3D mesh, and mandible reconstruction plates under the OPTIMUS and Real FIT brand names; and biodegradable CMF plating systems under the … Read more